Keywords: alnylam, partners, kyowa, rsv, drug, usa-based, pharmaceuticals

Alnylam partners with Kyowa for RSV drug

Article | 30 June 2008

Print This

USA-based Alnylam Pharmaceuticals has licensed the Asian rights to its ALN-RSV01, an RNAi therapeutic in Phase II clinical development for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in